Himeda, C. L., Jones, T. I., & Jones, P. L. (2020). Targeted epigenetic repression by CRISPR/dSaCas9 suppresses pathogenic DUX4-fl expression in FSHD. Mol Ther Methods Clin Dev.
Chicago ZitierstilHimeda, Charis L., Takako I. Jones, und Peter L. Jones. "Targeted Epigenetic Repression By CRISPR/dSaCas9 Suppresses Pathogenic DUX4-fl Expression in FSHD." Mol Ther Methods Clin Dev 2020.
MLA ZitierstilHimeda, Charis L., Takako I. Jones, und Peter L. Jones. "Targeted Epigenetic Repression By CRISPR/dSaCas9 Suppresses Pathogenic DUX4-fl Expression in FSHD." Mol Ther Methods Clin Dev 2020.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.